Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates

Author:Woodson, Sophia   Gettings, Edward   Guo, Chu-Yueh   Klineova, Sylvia   Lee, Jong-Mi   Romero, Rebecca   Walker, Aljoeson   Fong, Kinyee   Mendoza, Jason   Belviso, Nicholas   Bian, Boyang   Lewin, James   Shankar, Sai   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.005  

Author Institution:University Hospitals, Cleveland, OH  Temple Health, Philadelphia, PA  University of California San Francisco Health, San Francisco, CA  Mount Sinai, New York, NY  Stanford Medicine, Palo Alto, CA  University of Texas Health, San Antonio, TX  Medical University of South Carolina, Charleston, SC  Biogen, Cambridge, MA  

Change in Disease Modifying Therapy from DMF to DRF in People with Multiple Sclerosis and the Impact on CD4/CD8 T Cells

Author:Rahaman, Fatema   Jo, Matthew   Weller, Joanna   Kaczmarek, Olivia   Jaenicke, Kaitlyn   Baek, Steven   Buhse, Marijean   Bumstead, Barbara   Zarif, Myassar   Mendoza, Jason   Smrtka, Jennifer   Scott, Nicole   Lewin, James   Gudesblatt, Mark   

Session Name:P8: Multiple Sclerosis: Non-MS CNS Neuroinflammatory Diseases and Progressive MS and Remyelination/Neuroprotection  

Topic:Multiple Sclerosis  

Program Number:P8.016  

Author Institution:South Shore Neurologic Associates, P.C., Patchogue, NY  South Shore Neurologic Associates, P.C., Mount Sinai, NY  Biogen, Cambridge, MA  Biogen, Chapel Hill, NC  Biogen, Seaford, NY  Biogen, Framingham, MA